Case Study: a Fortune 100 pharmaceutical company achieves global labeling compliance and cost savings with Acolad

A Acolad Case Study

Preview of the A Fortune 100 pharmaceutical company Case Study

Identifying Local label Deviations and Ensuring Global and Local Compliance for Pharmaceutical Companies

A Fortune 100 pharmaceutical company faced a severe compliance challenge, having lost visibility into the local labeling of its global drug portfolio. This created the risk of deviations between its core Company Core Data Sheet and the information submitted to health authorities in approximately 100 countries. The company engaged vendor Acolad and its Life Sciences service to identify and rectify these labeling discrepancies.

Acolad implemented a novel three-step solution: retranslating all local labels into English, conducting a linguistic review for compliance, and performing a detailed labeling assessment on over 21,000 pieces of artwork. This process allowed the customer to pass its health authority inspection and achieve significant financial savings, with over $500,000 in translation memory savings and nearly $750,000 in volume and process refinement savings. Acolad continues to provide ongoing services to maintain compliance through a new centralized workflow.


View this case study…

Acolad

28 Case Studies